Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

NPPA Approves 50 percent Price Increase of 8 essential drugs, details

MD Bureau15 Oct 2024 1:38 PM IST

Delhi: The National Pharmaceutical Pricing Authority (NPPA) has announced a 50% increase in the ceiling prices of eleven scheduled formulations...

Bayer seeks EU nod to third indication of Darolutamide

MD Bureau15 Oct 2024 12:29 PM IST

Berlin: Bayer said on Monday that it has applied to the EU's drugs regulator for the use of Nubeqa, also known as darolutamide, in combination with...

India's pharma industry sets global standard, saves billions for US healthcare, says Union Health Secretary

MD Bureau15 Oct 2024 9:30 AM IST

The medicines from Indian companies provided 219 billion USD savings to the US healthcare system in 2022.

Six Pharma Suppliers Blacklisted in Five Years for Failing Quality Standards: MoS Anupriya Patel

Indian Pharma Market Grows 5.3% in September, Sun Pharma, Cipla take the lead: Pharmarack report

Farhat Nasim14 Oct 2024 5:45 PM IST

New Delhi: The Indian Pharmaceutical Market (IPM) witnessed a growth of 5.3% in September 2024, primarily driven by the robust performance of key...

Health Ministry Bans Chlorpheniramine Phenylephrine Combo for Children Below 4, Mandates Warning Labels

DCGI bans this popular anti-cold FDC for children under 4

Farhat Nasim14 Oct 2024 4:25 PM IST

New Delhi: The Drug Controller General of India (DCGI) has banned use of popular anti-cold cocktail medicine combination for children under four years...

Sun Pharma, Moebius Medical symptomatic knee osteoarthritis treatment MM-II

Rs 9.81 crore expenditure on Conference fees, accommodation to doctors, Business Promotion done by Sun Pharma disallowed: IT Tribunal

Farhat Nasim13 Oct 2024 12:15 PM IST

Ahmedabad: The Income Tax Appellate Tribunal (ITAT) in Ahmedabad has upheld the disallowance of more than Rs 9.81 crore incurred by Sun Pharma...

GST on Key Anti-Cancer Drugs Trastuzumab, Osimertinib, Durvalumab Slashed to 5%, Customs Duty Waived: MoS Health

Anti cancer medicines now under Schedule H2 of Drugs Rules, Here is what it means

Farhat Nasim12 Oct 2024 12:30 PM IST

New Delhi: In order to track the movement of anti-cancer drugs and prevent counterfeiting, the Drug Technical Advisory Board (DTAB) has agreed to...

Soon, harsher penalties for submitting false data for drug approval

Farhat Nasim11 Oct 2024 3:04 PM IST

New Delhi: Soon, there will be a stringent action against pharma companies who submit forged or false data for drug approval for sales in the...

Pharma-sponsored Indian CMEs allowed, but Govt sets speaker-to-participant ratios for such events

Farhat Nasim10 Oct 2024 4:08 PM IST

New Delhi: Noting that pharma-sponsored Continuing Medical Education (CME)/ Continuing Professional Development (CPD) programs that are being...

Indian branded pharma Sector sees a decline in growth: Report

Farhat Nasim9 Oct 2024 6:54 PM IST

Companies such as Dr Reddys Laboratories (DRRD), Zydus Lifesciences (ZYDUSLIF), Lupin (LPC), and Mankind Pharma (MANKIND) expected to outperform on a...

Delhi HC Dismisses Plea Against MCC Withdrawing Conversion of SC Seats to General Category

Sun's RACIRAFT Vs JB Pharma's RANRAFT: Delhi HC gives interim trademark protection to Sun Pharma

Farhat Nasim7 Oct 2024 6:07 PM IST

New Delhi: In a respite to drug major Sun Pharmaceutical Industries Ltd, the Delhi High Court has granted an interim injunction restraining JB...

Regulatory Action Ahead for Entod Pharma: CDSCO directs Gujarat FDCA to act on PresVu claims

Farhat Nasim7 Oct 2024 4:55 PM IST

New Delhi: Further challenges mount for Entod Pharmaceuticals as the Central Drugs Standard Control Organisation (CDSCO) has directed the Food and...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok